Related Experiment Video
Updated: Mar 19, 2026
09:31
In Vivo, Percutaneous, Needle Based, Optical Coherence Tomography of Renal Masses
Published on: March 30, 2015
9.3K
Cost-effectiveness of Management Options for Small Renal Mass: A Systematic Review
Ye Wang1, Yu-Wei Chen, Jeffrey J Leow
1*Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School †Harvard School of Public Health §Division of Urology, Brigham and Women's Hospital, Boston, MA ‡College of Physicians and Surgeons, Columbia University, New York City, NY.
American Journal of Clinical Oncology
|June 21, 2016
Summary
For small renal masses (SRMs), ablation is more cost-effective than surgery. Laparoscopic partial nephrectomy is also cost-effective compared to open surgery, with renal mass biopsy being cost-effective in the US.
Area of Science:
- Urology
- Health Economics
- Oncology
Background:
- Small renal masses (SRMs) present significant management challenges due to high surgical costs.
- Evaluating the economic impact of different treatment strategies is crucial for optimal resource allocation.
Purpose of the Study:
- To systematically review and evaluate the cost-effectiveness of various management options for SRMs.
- To synthesize existing economic evidence to guide clinical and policy decisions.
Main Methods:
- A comprehensive systematic literature search was conducted across six databases (inception to August 2015).
- Inclusion criteria focused on full economic evaluations of SRM management options published in English.
- Six studies met the inclusion criteria for analysis.
Main Results:
- Ablation therapy was found to be more cost-effective than nephron-sparing surgery for SRMs.
- Laparoscopic partial nephrectomy demonstrated superior cost-effectiveness compared to the open surgical approach.
- Renal mass biopsy was cost-effective for immediate treatment in the United States, but not in Canada.
Conclusions:
- Current evidence suggests that ablation and laparoscopic partial nephrectomy are cost-effective management strategies for SRMs.
- Geographical variations exist in the cost-effectiveness of renal mass biopsy.
- Further research, including international cost-effectiveness analyses, is recommended to address knowledge gaps.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
586
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
586
01:30Urinary Tract Calculi III: Medical Management
312
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
312
01:25Urinary Tract Calculi VI: Surgical Management
775
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
775
01:26Nephrotic Syndrome II : Assessment and Medical Management
300
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
300
01:08Renal Drug Clearance: Comparison Between Renal Excretion Methods
735
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
735
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
292
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
292